Home > Research > Publications & Outputs > Multi-arm clinical trials with treatment selection

Research

Associated organisational units

Electronic data

  • cli%2E15%2E13

    Rights statement: This work is licensed under the Creative Commons Attribution-NonCommercial 3.0 Unported License

    Final published version, 1.06 MB, PDF document

    Available under license: CC BY-NC

Links

Text available via DOI:

Keywords

View graph of relations

Multi-arm clinical trials with treatment selection: what can be gained and at what price?

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published
<mark>Journal publication date</mark>04/2015
<mark>Journal</mark>Clinical Investigation
Issue number4
Volume5
Number of pages7
Pages (from-to)393-399
Publication StatusPublished
<mark>Original language</mark>English

Abstract

With current success rates of confirmatory studies being only around 50%, new approaches to drug development are paramount. Many trials fail simply because ineffective treatments are identified too late. In this paper, we discuss the utility of multi-arm studies with treatment selection as a potential strategy that can reduce the high attrition rate. We illustrate the large gains in efficiency that are possible based on an example in Alzheimer's disease while outlining the additional challenges that need to be overcome to implement such studies.

Bibliographic note

This work is licensed under the Creative Commons Attribution-NonCommercial 3.0 Unported License